These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema. Khemasuwan D; Sorensen J; Griffin DC Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674 [TBL] [Abstract][Full Text] [Related]
3. tPA/DNase for Complicated Parapneumonic Effusions and Empyemas. Maiga A; Pinkerman R; Deppen SA; Scruggs J; Mcguire P; Tarpley JL; Grogan EL Am Surg; 2017 Dec; 83(12):1458-1459. PubMed ID: 29336772 [No Abstract] [Full Text] [Related]
4. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema. Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084 [TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients. Israel EN; Blackmer AB Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857 [TBL] [Abstract][Full Text] [Related]
6. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241 [TBL] [Abstract][Full Text] [Related]
8. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema. Smith D; Shaw H; Ryder T Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897 [TBL] [Abstract][Full Text] [Related]
10. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Wells RG; Havens PL Radiology; 2003 Aug; 228(2):370-8. PubMed ID: 12893898 [TBL] [Abstract][Full Text] [Related]
11. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose. Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458 [TBL] [Abstract][Full Text] [Related]
12. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study. Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784 [TBL] [Abstract][Full Text] [Related]
13. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status. Barthwal MS Indian J Chest Dis Allied Sci; 2008; 50(3):277-82. PubMed ID: 18630794 [TBL] [Abstract][Full Text] [Related]
15. Intrapleural fibrinolysis and DNase versus video-assisted thoracic surgery (VATS) for the treatment of pleural empyema (FIVERVATS): protocol for a randomised, controlled trial - surgery as first-line treatment. Christensen TD; Bendixen M; Skaarup SH; Jensen JU; Petersen RH; Christensen M; Licht P; Neckelmann K; Bibby BM; Møller LB; Bodtger U; Borg MH; Saghir Z; Langfeldt S; Harders SMW; Bedawi EO; Naidu B; Rahman N; Laursen CB BMJ Open; 2022 Mar; 12(3):e054236. PubMed ID: 35264347 [TBL] [Abstract][Full Text] [Related]
16. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159 [TBL] [Abstract][Full Text] [Related]
18. Fibrinolytics in the treatment of parapneumonic effusions. Bouros D; Schiza S; Siafakas N Monaldi Arch Chest Dis; 1999 Jun; 54(3):258-63. PubMed ID: 10441983 [TBL] [Abstract][Full Text] [Related]
19. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema. Cameron R Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554 [TBL] [Abstract][Full Text] [Related]
20. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia. Muhammad Redzwan SRA Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]